VNDA  valuation analysis

Name: Vanda Pharmaceuticals Inc
Description: Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 10, 2021
Market cap: $1.02B (1135th)
Sales(TTM): $248.64M (1224th)
Earnings(TTM): $23.34M (909th)

FFER: 1.06 (why)
Actual price: $18.65
FFEThis is Vanda Pharmaceuticals Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $17.54
Quantile: VNDA is priced correctly given its fundamentals.
Prices as of EOD 2021-02-26
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Vanda Pharmaceuticals Inc
"Biotechnology" industry
Sales / MarketCap
Vanda Pharmaceuticals Inc
"Biotechnology" industry
Book / MarketCap
Vanda Pharmaceuticals Inc
"Biotechnology" industry
Equity / Assets
Vanda Pharmaceuticals Inc
"Biotechnology" industry